A Saudi Arabian prince accused of failing to honor an agreement to pay Boston Children's $3.5 million for care provided to a Saudi Arabian child denies owing the hospital, according to The Boston Globe.
Pharmacy
Zolgensma, recently approved by the FDA, tops GoodRx's list of the 10 most expensive drugs in the U.S., with a $2.1 million price tag.
Nine pharmaceutical companies or suppliers that filed for bankruptcy since Jan. 1, as reported by Becker's Hospital Review:
Catalyst Pharmaceuticals has sued the FDA, accusing the agency of violating provisions of the law and its rights to exclusivity for its rare disease drug Firdapse when it approved a lower-cost rival drug, according to healthcare news website STAT.
Florida Gov. Ron DeSantis signed a bill to create a program to import prescription drugs from Canada and another program that would authorize importation from other countries as well, according to the Tampa Bay Times.
Advertisement
Jacobus Pharmaceutical has priced its medication at $80 per pill, less than half the price of a similar pill sold by its rival, Catalyst Pharmaceuticals, according to STAT.
An Oklahoma judge has declined to approve an $85 million opioid settlement between Oklahoma and Teva Pharmaceuticals until attorneys from both sides provide more information about the deal, according to legal news website Law 360.
Below is a list of prescription drugs that generated the most sales for 10 top pharma companies in 2018.
Hospitals participating in the 340B drug discount program saved an average of $11.8 million per year, according to a new report from 340B Health.
Teva Pharmaceuticals has recalled an additional six lots of bulk losartan potassium tablets, expanding a nationwide recall originally initiated in April, the FDA announced June 11.